Closed
Award
Calculated transaction value
$0

Khattar Jack A. President, CEO

SUPN
Transaction date Oct 30, 2026
Public filing date Nov 2, 2026
Filing lag Filed 3 days later

SUPN daily price context

Close on/before transaction
$41.92 Oct 30, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Restricted Stock Unit on Common Stock
Quantity / price
400,000 shares @ $0
SEC ownership
Direct
Transaction code
A
Form
4
Filing identifier
0001539937-26-000014
Filing cohort

Transactions in this filing

Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Supernus Pharmaceuticals, Inc. SUPN Current Award Oct 30, 2026 $0